IGF-1R Modulation of Acute GH-Induced STAT5 Signaling: Role of Protein Tyrosine Phosphatase Activity
Autor: | Jing Jiang, Stuart J. Frank, Yujun Gan, Yingzi Chang, Yue Zhang, Thomas L. Clemens, Andrew J. Paterson, Keyong Du, Zhong Yin Zhang, Ashiya Buckels |
---|---|
Rok vydání: | 2013 |
Předmět: |
Ubiquitin-Protein Ligases
Mice Transgenic Protein tyrosine phosphatase Biology Receptor tyrosine kinase Receptor IGF Type 1 Mice Endocrinology STAT5 Transcription Factor Animals Humans Phosphorylation Molecular Biology Cells Cultured Benzofurans Original Research Protein Tyrosine Phosphatase Non-Receptor Type 1 Osteoblasts Janus kinase 2 Nuclear Proteins JAK-STAT signaling pathway General Medicine Janus Kinase 2 Molecular biology Growth Hormone Quinolines biology.protein Janus kinase Protein Processing Post-Translational Tyrosine kinase Platelet-derived growth factor receptor Proto-oncogene tyrosine-protein kinase Src |
Zdroj: | Molecular Endocrinology. 27:1969-1979 |
ISSN: | 1944-9917 0888-8809 |
Popis: | GH is a potent anabolic and metabolic factor that binds its cell surface receptor (GHR), activating the GHR-associated tyrosine kinase, Janus kinase 2, which phosphorylates and activates the latent transcription factor, signal transducer and activator of transcription 5 (STAT5). Some GH actions are mediated by the elaboration of IGF-1, which exerts effects by binding and activating the heterotetrameric tyrosine kinase growth factor receptor, IGF-1R. In addition to this GH-GHR-IGF-1-IGF-1R scheme, we have demonstrated in primary osteoblasts and in islet β-cells that then deletion or silencing of IGF-1R results in diminished GH-induced STAT5 phosphorylation, suggesting that the presence of IGF-1R may facilitate GH signaling. In this study, we explore potential roles for protein tyrosine phosphatase activity in modulating GH-induced signaling, comparing conditions in which IGF-1R is present or diminished. We confirm that in mouse primary osteoblasts harboring loxP sites flanking the IGF-1R gene, infection with an adenovirus that expresses the Cre recombinase results in IGF-1R deletion and diminished acute GH-induced STAT5 phosphorylation. Furthermore, we present a new model of IGF-1R silencing, in which expression of short hairpin RNA directed at IGF-1R greatly reduces IGF-1R abundance in LNCaP human prostate cancer cells. In both models, treatment with a chemical inhibitor of protein tyrosine phosphatase-1B (PTP-1B), but not one of src homology region 2 domain-containing phosphotase-1 (SHP-1) and SHP-2, reverses the loss of GH-induced STAT5 phosphorylation in cells lacking IGF-1R but has no effect in cells with intact IGF-1R. Furthermore, expression of either a dominant-negative PTP-1B or the PTP-1B-interacting inhibitory protein, constitutive photomorphogenesis 1, also rescues acute GH-induced STAT5 signaling in IGF-1R-deficient cells but has no effect in IGF-1R replete cells. By expressing a substrate-trapping mutant PTP-1B, we demonstrate that tyrosine phosphorylated Janus kinase-2 is a PTP-1B substrate only in cells lacking IGF-1R. Collectively, our data suggest that IGF-1R positively regulates acute GH signaling by preventing access of PTP-1B activity to Janus kinase 2 and thereby preventing PTP-1B-mediated suppression of GH-induced STAT5 activation. |
Databáze: | OpenAIRE |
Externí odkaz: |